Literature DB >> 26668213

Caregiver Sexual and HPV Communication Among Female Survivors of Childhood Cancer.

Courtney Peasant1, Rebecca H Foster2, Kathryn M Russell3, Brianne E Favaro3, James L Klosky4.   

Abstract

Human papillomavirus (HPV) vaccination is recommended for all female survivors of childhood cancer; yet, it is underused. Parent-child sexual communication and health care provider recommendation for HPV vaccination influence familial vaccination decisions. However, caregivers may be less likely to discuss sexual health issues with survivors as compared to healthy peers. Therefore, this study compared mothers of daughters with/without history of childhood cancer on measures of sexual communication, HPV-specific communication, and health care provider recommendation for HPV vaccination, and examined the effects of sociodemographic and medical factors on these measures. There were no differences between mothers of survivors/noncancer survivors on the outcomes (Ps > .05). Among all mothers, daughter's age was associated with sexual communication (Ps < .05). Household income and daughter's age were associated with health care provider recommendation for vaccination (Ps < .05). Among mothers of survivors, daughter's age at diagnosis was associated with sexual communication, HPV-specific communication, and health care provider recommendation for vaccination (Ps < .05). Findings have implications for the role of health care providers as advocates for mother-daughter sexual communication and HPV vaccination, especially among survivors of childhood cancer.
© 2015 by Association of Pediatric Hematology/Oncology Nurses.

Entities:  

Keywords:  HPV vaccination; cancer survivorship; mother-daughter sexual communication; provider recommendation

Mesh:

Substances:

Year:  2015        PMID: 26668213      PMCID: PMC5790192          DOI: 10.1177/1043454215607339

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  24 in total

1.  Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.

Authors:  James L Klosky; Kathryn M Russell; Kristin E Canavera; Heather L Gammel; Jason R Hodges; Rebecca H Foster; Gilbert R Parra; Jessica L Simmons; Daniel M Green; Melissa M Hudson
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-27

2.  A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia.

Authors:  R T Brown; M B Sawyer; G Antoniou; I Toogood; M Rice; N Thompson; A Madan-Swain
Journal:  J Dev Behav Pediatr       Date:  1996-12       Impact factor: 2.225

3.  Factor analysis and psychometric properties of the Mother-Adolescent Sexual Communication (MASC) instrument for sexual risk behavior.

Authors:  Mary Foster Cox; Tracy K Fasolino; Abbas S Tavakoli
Journal:  J Nurs Meas       Date:  2008

4.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

5.  Parental decision making about the HPV vaccine.

Authors:  Jennifer D Allen; Megan K D Othus; Rachel C Shelton; Yi Li; Nancy Norman; Laura Tom; Marcela G del Carmen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09       Impact factor: 4.254

6.  Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer.

Authors:  Paul Craig Nathan; Christopher Keller Daugherty; Kristen Elizabeth Wroblewski; Mackenzie Louise Kigin; Tom Vernon Stewart; Fay Jarmila Hlubocky; Eva Grunfeld; Marie Elisabeth Del Giudice; Leigh-Anne Evelyn Ward; James Mahlon Galliher; Kevin Charles Oeffinger; Tara Olive Henderson
Journal:  J Cancer Surviv       Date:  2013-03-08       Impact factor: 4.442

7.  Human papillomavirus vaccination in female pediatric cancer survivors.

Authors:  Lindsey Hoffman; M Fatih Okcu; ZoAnn E Dreyer; Hilary Suzawa; Rosalind Bryant; Amy B Middleman
Journal:  J Pediatr Adolesc Gynecol       Date:  2012-07-24       Impact factor: 1.814

8.  Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2).

Authors:  Branlyn E Werba; Wendy Hobbie; Anne E Kazak; Richard F Ittenbach; Anne F Reilly; Anna T Meadows
Journal:  Pediatr Blood Cancer       Date:  2007-06-15       Impact factor: 3.167

9.  Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.

Authors:  Tara O Henderson; John Whitton; Marilyn Stovall; Ann C Mertens; Pauline Mitby; Debra Friedman; Louise C Strong; Sue Hammond; Joseph P Neglia; Anna T Meadows; Leslie Robison; Lisa Diller
Journal:  J Natl Cancer Inst       Date:  2007-02-21       Impact factor: 11.816

10.  Risky health behavior among adolescents in the childhood cancer survivor study cohort.

Authors:  James L Klosky; Carrie R Howell; Zhenghong Li; Rebecca H Foster; Ann C Mertens; Leslie L Robison; Kirsten K Ness
Journal:  J Pediatr Psychol       Date:  2012-03-16
View more
  1 in total

1.  5-aminolevulinic acid-mediated photodynamic therapy effectively ameliorates HPV-infected cervical intraepithelial neoplasia.

Authors:  Yi Chen; Ying Xu; Zhengrong Zhang; Zhenhong Xiong; Dan Wu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.